Contemporary use and outcome of Cabrol shunt in type A aortic dissection surgery: insight from China 5A study.
Hong Liu, Bing-Qi Sun, Si-Chong Qian...
https://pubmed.ncbi.nlm.nih.gov/38070883/Actively Recruiting
Led by Nanjing Medical University · Updated on 2026-02-09
10000
Participants Needed
34
Research Sites
N/A
Total Duration
Researchers are investigating acute aortic syndrome AAS, a serious and life-threatening heart condition where inflammation plays a significant role in its development and progression. This large observational study involves 20 cardiovascular centers in China collaborating to understand inflammatory responses and anti-inflammatory treatments in patients undergoing surgery for AAS. The study aims to assess how inflammation and anti-inflammatory strategies affect patient outcomes after surgery, including complications and survival. The study enrolls adult patients who have undergone surgery for AAS, which includes various types of aortic injuries such as dissection, penetrating ulcers, or hematomas. Participants may have received medical therapy, open surgery, endovascular repair, or hybrid procedures, sometimes combined with other cardiac surgeries. Data about their inflammatory responses and clinical results are collected through designed forms and analyzed using statistical software. This observational study began in 2016 and will continue enrolling patients until 2040. Participants will be followed over time to evaluate key outcomes like severe inflammatory reactions within 7 days after surgery and operative mortality within 30 days. Researchers will also monitor other complications such as organ dysfunction, stroke, kidney injury, infections, bleeding, and length of intensive care stay. The study gathers detailed information through clinical data collection and monitors these outcomes to better understand and improve management for patients with AAS over the long term.
CONDITIONS
Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
H
Hong Liu, MD
H
Hai-yang LI, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nanjing Medical University
Lead Sponsor
Beijing Anzhen Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 15 years
Participants who undergo routine care for acute aortic syndrome are observed to understand inflammatory responses, anti-inflammatory strategies, and clinical outcomes over time.
Visits scheduled based on routine clinical care and follow-up needs
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Hong Liu, Bing-Qi Sun, Si-Chong Qian...
https://pubmed.ncbi.nlm.nih.gov/38070883/Hong Liu, Hai-Yang Li, Yi-Lin Li...
https://pubmed.ncbi.nlm.nih.gov/38939657/Hong-Lei Zhao, Zhi-Wei Tang, Yi-Fei Diao...
https://pubmed.ncbi.nlm.nih.gov/37713048/Hong Liu, Yi-Fei Diao, Yong Feng Shao...
https://pubmed.ncbi.nlm.nih.gov/38445499/Hong Liu, Si-Chong Qian, Hai-Yang Li...
https://pubmed.ncbi.nlm.nih.gov/38383323/Nanjing Medical University
Lead Sponsor
Beijing Anzhen Hospital
Collaborating Sponsor